Activity-based probes in pathogenic bacteria: Investigating drug targets and molecule specificity

被引:1
作者
Lembke, Hannah K. [1 ]
Carlson, Erin E. [1 ,2 ,3 ,4 ]
机构
[1] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Bacterial pathogens; Antibiotics; Activity-based probes; STRATEGIES; INHIBITORS; UREAS;
D O I
10.1016/j.cbpa.2023.102359
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bacteria comprise complex communities within our bodies and largely have beneficial roles, however a small percentage are pathogenic. While all pathogens are important to public health, immediate action is necessary to combat bacterial strains developing pan- and multi-resistance to antibiotics. As present therapeutics fail to tackle this problem, novel strategies are required to address this threat. Activity-based probes (ABPs) are one method to investigate proteins of interest in pathogens. These probes can serve multiple purposes to better our understanding of bacterial pathogenicity. Herein, we highlight recent studies that used ABPs to identify new drug targets or visualize antibiotic resistance- or bacterial virulenceassociated proteins, and introduce strategies to determine the specificity of ABPs within a targeted enzyme class.
引用
收藏
页数:8
相关论文
共 42 条
  • [1] Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]
  • [2] Al-Tawfiq JA, 2022, INFECTION, V50, P553, DOI 10.1007/s15010-021-01709-3
  • [3] [Anonymous], 2022, COVID-19: U.S. Impact on Antimicrobial Resistance, DOI [10.15620/cdc:117915, DOI 10.15620/CDC:117915]
  • [4] [Anonymous], 2023, Global Research Agenda for Antimicrobial Resistance in Human Health
  • [5] [Anonymous], 2019, CdcAntibiotic Resistance Threats in the United States, 2019
  • [6] The promise and peril of chemical probes
    Arrowsmith, Cheryl H.
    Audia, James E.
    Austin, Christopher
    Baell, Jonathan
    Bennett, Jonathan
    Blagg, Julian
    Bountra, Chas
    Brennan, Paul E.
    Brown, Peter J.
    Bunnage, Mark E.
    Buser-Doepner, Carolyn
    Campbell, Robert M.
    Carter, Adrian J.
    Cohen, Philip
    Copeland, Robert A.
    Cravatt, Ben
    Dahlin, Jayme L.
    Dhanak, Dashyant
    Edwards, Aled M.
    Frye, Stephen V.
    Gray, Nathanael
    Grimshaw, Charles E.
    Hepworth, David
    Howe, Trevor
    Huber, Kilian V. M.
    Jin, Jian
    Knapp, Stefan
    Kotz, Joanne D.
    Kruger, Ryan G.
    Lowe, Derek
    Mader, Mary M.
    Marsden, Brian
    Mueller-Fahrnow, Anke
    Mueller, Susanne
    O'Hagan, Ronan C.
    Overington, John P.
    Owen, Dafydd R.
    Rosenberg, Saul H.
    Roth, Brian
    Ross, Ruth
    Schapira, Matthieu
    Schreiber, Stuart L.
    Shoichet, Brian
    Sundstrom, Michael
    Superti-Furga, Giulio
    Taunton, Jack
    Toledo-Sherman, Leticia
    Walpole, Chris
    Walters, Michael A.
    Willson, Timothy M.
    [J]. NATURE CHEMICAL BIOLOGY, 2015, 11 (08) : 536 - 541
  • [7] Bloom BR AR, 2017, MAJOR INFECT DIS, V6
  • [8] Comparison of Bioorthogonal β-Lactone Activity-Based Probes for Selective Labeling of Penicillin-Binding Proteins
    Brown, Nathaniel W., Jr.
    Shirley, Joshua D.
    Marshall, Andrew P.
    Carlson, Erin E.
    [J]. CHEMBIOCHEM, 2021, 22 (01) : 193 - 202
  • [9] Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191
  • [10] Fluorescent Triazole Urea Activity-Based Probes for the Single-Cell Phenotypic Characterization of Staphylococcus aureus
    Chen, Linhai
    Keller, Laura J.
    Cordasco, Edward
    Bogyo, Matthew
    Lentz, Christian S.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (17) : 5643 - 5647